Xylem/$XYL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Xylem

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.

Ticker

$XYL

Primary listing

NYSE

Employees

23,000

Xylem Metrics

BasicAdvanced
$36B
38.34
$3.84
1.13
$1.56
1.09%

What the Analysts think about Xylem

Analyst ratings (Buy, Hold, Sell) for Xylem stock.

Bulls say / Bears say

Xylem’s second-quarter 2025 results beat expectations with 6% organic revenue growth and a 16% increase in adjusted earnings per share, and the company raised its full-year 2025 revenue guidance to $8.9–9.0 billion and adjusted EPS to $4.70–4.85, reflecting strong execution across all segments (Nasdaq)
In first-quarter 2025, Xylem posted adjusted EPS of $1.03, beating the Zacks consensus of $0.95 by 8.42%, and delivered $2.07 billion in revenue, exceeding the $2.04 billion estimate by 1.26%, demonstrating a solid start to the year (Nasdaq)
Despite tariff pressures, Q1 2025 organic revenue grew 3% and adjusted EBITDA margin expanded by 120 basis points to 20.4%, underscoring Xylem’s operational discipline and resilience amid macroeconomic headwinds (Investing.com)
First-quarter 2025 orders declined 3.9% year-over-year to $2.158 billion and fell 2.4% on an organic basis, signalling potential softening demand across segments (SEC)
Foreign currency translation headwinds reduced first-quarter 2025 revenue by $26 million, highlighting Xylem’s exposure to currency risks in its global operations (SEC)
On April 23, 2025, XYL shares rose only 1.48% compared with a 1.67% gain in the S&P 500 and a 1.07% rise in the Dow, while trading 22.41% below their 52-week high, indicating investor caution (MarketWatch)
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2025.

Xylem Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Xylem Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $XYL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs